These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 23659834

  • 1. The efficacy, safety and cost-effectiveness of hydrotalcite versus esomeprazole in on-demand therapy of NERD: A multicenter, randomized, open-label study in China.
    Xiao YL, Nie YQ, Hou XH, Xie PY, Fang JY, Yuan YZ, Zhou LY, Zhao NQ, Chen MH.
    J Dig Dis; 2013 Sep; 14(9):463-8. PubMed ID: 23659834
    [Abstract] [Full Text] [Related]

  • 2. Cost analysis of long-term treatment of patients with symptomatic gastroesophageal reflux disease (GERD) with esomeprazole on-demand treatment or esomeprazole continuous treatment: an open, randomized, multicenter study in Switzerland.
    Szucs T, Thalmann C, Michetti P, Beglinger C.
    Value Health; 2009 Sep; 12(2):273-81. PubMed ID: 18783388
    [Abstract] [Full Text] [Related]

  • 3. The efficacy of hydrotalcite compared with OTC famotidine in the on-demand treatment of gastroesophageal reflux disease: a non-inferiority trial.
    Konturek JW, Beneke M, Koppermann R, Petersen-Braun M, Weingärtner U.
    Med Sci Monit; 2007 Jan; 13(1):CR44-9. PubMed ID: 17179910
    [Abstract] [Full Text] [Related]

  • 4. [Long-term treatment of patients with symptomatic gastroesophageal reflux disease comparing costs and efficacy over 6 months of treatment with Nexium On-Demand Treatment or Nexium continuous treatment. An open, randomised multi-center study].
    Beglinger C, Thalmann C, Szucs T, Michetti P.
    Praxis (Bern 1994); 2006 Mar 29; 95(13):483-7. PubMed ID: 16602668
    [Abstract] [Full Text] [Related]

  • 5. Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease.
    Bayerdörffer E, Bigard MA, Weiss W, Mearin F, Rodrigo L, Dominguez Muñoz JE, Grundling H, Persson T, Svedberg LE, Keeling N, Eklund S.
    BMC Gastroenterol; 2016 Apr 14; 16():48. PubMed ID: 27080034
    [Abstract] [Full Text] [Related]

  • 6. Predictors of heartburn resolution and erosive esophagitis in patients with GERD.
    Orlando RC, Monyak JT, Silberg DG.
    Curr Med Res Opin; 2009 Sep 14; 25(9):2091-102. PubMed ID: 19601705
    [Abstract] [Full Text] [Related]

  • 7. The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trial.
    Moayyedi P, Armstrong D, Hunt RH, Lei Y, Bukoski M, White RJ.
    Am J Gastroenterol; 2010 Nov 14; 105(11):2341-6. PubMed ID: 20842110
    [Abstract] [Full Text] [Related]

  • 8. Is the use of esomeprazole in gastroesophageal reflux disease a cost-effective option in Poland?
    Petryszyn P, Staniak A, Grzegrzolka J.
    J Comp Eff Res; 2016 Mar 14; 5(2):169-78. PubMed ID: 26946951
    [Abstract] [Full Text] [Related]

  • 9. On-demand treatment of acute heartburn with the antacid hydrotalcite compared with famotidine and placebo: randomized double-blind cross-over study.
    Holtmeier W, Holtmann G, Caspary WF, Weingärtner U.
    J Clin Gastroenterol; 2007 Jul 14; 41(6):564-70. PubMed ID: 17577112
    [Abstract] [Full Text] [Related]

  • 10. Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease.
    Wu JC, Lai LH, Chow DK, Wong GL, Sung JJ, Chan FK.
    Neurogastroenterol Motil; 2011 Feb 14; 23(2):155-60, e31. PubMed ID: 21087355
    [Abstract] [Full Text] [Related]

  • 11. [Hydrotalcite in the treatment of reflux esophagitis: a multicenter clinical study].
    Hydrotalcid Multicenter Clinical Cooperative Group.
    Zhonghua Nei Ke Za Zhi; 2001 Dec 14; 40(12):819-22. PubMed ID: 16206671
    [Abstract] [Full Text] [Related]

  • 12. Six-month management of patients following treatment for gastroesophageal reflux disease symptoms -- a Norwegian randomized, prospective study comparing the costs and effectiveness of esomeprazole and ranitidine treatment strategies in a general medical practitioners setting.
    Hansen AN, Wahlqvist P, Jørgensen E, Bergheim R, Fagertun H, Lund H, Moum B.
    Int J Clin Pract; 2005 Jun 14; 59(6):655-64. PubMed ID: 15924593
    [Abstract] [Full Text] [Related]

  • 13. Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease.
    Pace F, Negrini C, Wiklund I, Rossi C, Savarino V, ITALIAN ONE INVESTIGATORS STUDY GROUP.
    Aliment Pharmacol Ther; 2005 Aug 15; 22(4):349-56. PubMed ID: 16098002
    [Abstract] [Full Text] [Related]

  • 14. Comparison of risk factors and clinical responses to proton pump inhibitors in patients with erosive oesophagitis and non-erosive reflux disease.
    Lee ES, Kim N, Lee SH, Park YS, Kim JW, Jeong SH, Lee DH, Jung HC, Song IS.
    Aliment Pharmacol Ther; 2009 Jul 01; 30(2):154-64. PubMed ID: 19392871
    [Abstract] [Full Text] [Related]

  • 15. Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease.
    Hughes DA, Bodger K, Bytzer P, de Herdt D, Dubois D.
    Pharmacoeconomics; 2005 Jul 01; 23(10):1031-41. PubMed ID: 16235976
    [Abstract] [Full Text] [Related]

  • 16. Randomised clinical trial: daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms.
    Moraes-Filho JP, Pedroso M, Quigley EM, PAMES Study Group.
    Aliment Pharmacol Ther; 2014 Jan 01; 39(1):47-56. PubMed ID: 24299323
    [Abstract] [Full Text] [Related]

  • 17. Effects of hydrotalcite combined with esomeprazole on gastric ulcer healing quality: A clinical observation study.
    Yang RQ, Mao H, Huang LY, Su PZ, Lu M.
    World J Gastroenterol; 2017 Feb 21; 23(7):1268-1277. PubMed ID: 28275307
    [Abstract] [Full Text] [Related]

  • 18. Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study.
    Tsai HH, Chapman R, Shepherd A, McKeith D, Anderson M, Vearer D, Duggan S, Rosen JP, COMMAND Study Group.
    Aliment Pharmacol Ther; 2004 Sep 15; 20(6):657-65. PubMed ID: 15352914
    [Abstract] [Full Text] [Related]

  • 19. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V, Youssef NN, Gilger MA, Traxler B, Illueca M.
    J Pediatr Gastroenterol Nutr; 2015 Jul 15; 60 Suppl 1():S24-30. PubMed ID: 26422095
    [Abstract] [Full Text] [Related]

  • 20. Indirect comparison of randomised controlled trials: comparative efficacy of dexlansoprazole vs. esomeprazole in the treatment of gastro-oesophageal reflux disease.
    Wu MS, Tan SC, Xiong T.
    Aliment Pharmacol Ther; 2013 Jul 15; 38(2):190-201. PubMed ID: 23718547
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.